1
Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
Condition(s): Meningococcal Infections Last Updated: March 26, 2012Completed
233 Clinical Trials for: Meningococcal Infection, Page 1 of 12
Hide Studies Not Seeking New Volunteers
2
Correlation Between Cytokines and the Severity of Meningococcal Disease
Condition(s): Meningococcemia Last Updated: June 14, 2011Completed
3
Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine
Condition(s): Meningococcal Infection Last Updated: March 28, 2013Completed
4
Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects
Condition(s): Meningococcal Disease Last Updated: September 3, 2009Completed
5
Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
Condition(s): Meningococcal Disease Last Updated: April 11, 2013Recruiting
6
A Case-control Study of the Efficacy of a New Serogroup A Meningococcal Conjugate Vaccine (MenAfriVac) in Mali and Niger
Condition(s): Meningococcal Disease Last Updated: February 18, 2013Withdrawn
7
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine (TetraMen-T) in Infants and Toddlers
Condition(s): Meningitis; Meningococcal Infection Last Updated: April 24, 2013Completed
8
Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations
Condition(s): Meningitis; Meningococcal Infection Last Updated: February 11, 2013Completed
9
Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age
Condition(s): Meningitis; Meningococcal Infection; Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Serotype b (Hib) Last Updated: February 5, 2013Recruiting
10
Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®
Condition(s): Meningitis; Meningococcal Infection Last Updated: December 14, 2009Completed
11
Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine
Condition(s): Meningitis; Meningococcal Infection Last Updated: December 3, 2012Completed
12
A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India
Condition(s): Meningococcal Infection; Meningitis Last Updated: February 2, 2012Completed
13
Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®
Condition(s): Meningitis; Meningococcal Infection Last Updated: November 30, 2009Completed
14
Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children
Condition(s): Meningitis; Meningococcal Infection Last Updated: March 28, 2013Enrolling by invitation
15
MenPF-1 - A New Vaccine Against Meningococcal Disease
Condition(s): Serogroup B Meningococcal Disease Last Updated: January 23, 2013Active, not recruiting
16
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
Condition(s): Meningitis; Meningococcal Infection Last Updated: January 7, 2010Completed
17
Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age
Condition(s): Meningococcal Infection Last Updated: October 25, 2006Completed
18
Dose Comparison Study of Menactra® in US Children
Condition(s): Meningitis; Meningococcal Infection; Neisseria Meningitidis Last Updated: December 22, 2010Completed
19
Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine
Condition(s): Meningococcal Infection; Haemophilus Influenzae Type b Infections Last Updated: October 27, 2008Completed
20
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
Condition(s): Meningococcal Infection; Haemophilus Influenzae Type b Infection Last Updated: October 18, 2012Completed
